#dialogue
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Transforming Scientific Innovation Into Patient Progress
WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has announced that CNBC “Squawk...
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Rare Disease Innovation
WASHINGTON, D.C. and NORWELL, Mass. — In an era defined by unprecedented scientific breakthroughs, the ultimate measure of...
Industry Leaders and Federal Officials to Convene for Landmark Rare Disease CEO Dialogue at NORD’s 2026 Breakthrough Summit
WASHINGTON, D.C. and NORWELL, Mass. — As scientific innovation continues to unlock unprecedented possibilities in the medical field,...
Becky Quick to Moderate High-Stakes Rare Disease CEO Leadership Dialogue at the 2026 NORD Breakthrough Summit
7 Oktober 2026
WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Diseases (NORD®) has announced that CNBC “Squawk Box” co-anchor...